Insight Molecular Diagnostics Inc. (IMDX) ownership: Top institutional holder: BROADWOOD CAPITAL INC ($39.14M). Insider activity: Neutral (10 buys, 10 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 11931839.00 | $39.14M | 2026-03-31 |
| AWM Investment Company, Inc. | 2806256.00 | $9.20M | 2026-03-31 |
| VANGUARD GROUP INC | 526675.00 | $3.95M | 2025-12-31 |
| PURA VIDA INVESTMENTS, LLC | 947134.00 | $3.11M | 2026-03-31 |
| Alyeska Investment Group, L.P. | 840777.00 | $2.76M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 537161.00 | $1.76M | 2026-03-31 |
| HEIGHTS CAPITAL MANAGEMENT, INC | 392545.00 | $1.29M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 262053.00 | $860170.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Buy | null | 2026-04-23 | |
| Buy | null | 2026-04-23 | |
| Buy | null | 2026-04-23 | |
| Buy | null | 2026-04-23 | |
| Buy | null | 2026-04-16 |
Back to IMDX overview · IMDX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.